637 related articles for article (PubMed ID: 32179573)
1. Antinociceptive and Immune Effects of Delta-9-Tetrahydrocannabinol or Cannabidiol in Male Versus Female Rats with Persistent Inflammatory Pain.
Britch SC; Goodman AG; Wiley JL; Pondelick AM; Craft RM
J Pharmacol Exp Ther; 2020 Jun; 373(3):416-428. PubMed ID: 32179573
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.
Britch SC; Craft RM
J Pain; 2023 Jan; 24(1):98-111. PubMed ID: 36122809
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol modulation of antinociceptive tolerance to Δ
Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol-Δ
Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ(9)-tetrahydrocannabinol in the rat.
Craft RM; Kandasamy R; Davis SM
Pain; 2013 Sep; 154(9):1709-1717. PubMed ID: 23707295
[TBL] [Abstract][Full Text] [Related]
6. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture.
Morris T; Cucinello-Ragland JA; Marks TJ; Prevost K; Glenn JF; Davenport GJ; Edwards S; Winsauer PJ
Pharmacol Biochem Behav; 2024 Feb; 235():173692. PubMed ID: 38128766
[TBL] [Abstract][Full Text] [Related]
7. No antinociceptive synergy between morphine and delta-9-tetrahydrocannabinol in male and female rats with persistent inflammatory pain.
Britch SC; Craft RM
Behav Pharmacol; 2021 Dec; 32(8):630-639. PubMed ID: 34561365
[TBL] [Abstract][Full Text] [Related]
8. Vaporized cannabis extract-induced antinociception in male vs female rats with persistent inflammatory pain.
Craft RM; Gogulski HY; Freels TG; Glodosky NC; McLaughlin RJ
Pain; 2023 Sep; 164(9):2036-2047. PubMed ID: 37027147
[TBL] [Abstract][Full Text] [Related]
9. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.
Eeswara A; Pacheco-Spiewak A; Jergova S; Sagen J
PLoS One; 2023; 18(3):e0282920. PubMed ID: 36913400
[TBL] [Abstract][Full Text] [Related]
10. Medical Cannabis Use and Inflammatory Cytokines and Chemokines Among Adult Chronic Pain Patients.
Ajrawat P; Yang Y; Wasilewski E; Leroux T; Ladha KS; Bhatia A; Singh M; Thaker S; Kapoor M; Furlan AD; Kotra LP; Clarke H
Cannabis Cannabinoid Res; 2024 Feb; 9(1):267-281. PubMed ID: 36342776
[No Abstract] [Full Text] [Related]
11. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
[TBL] [Abstract][Full Text] [Related]
12. A Critical Review of the Role of the Cannabinoid Compounds Δ
Jones É; Vlachou S
Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations.
Moore CF; Weerts EM
Psychopharmacology (Berl); 2022 May; 239(5):1397-1408. PubMed ID: 34652500
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination.
Linher-Melville K; Zhu YF; Sidhu J; Parzei N; Shahid A; Seesankar G; Ma D; Wang Z; Zacal N; Sharma M; Parihar V; Zacharias R; Singh G
PLoS One; 2020; 15(6):e0234176. PubMed ID: 32497151
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
[TBL] [Abstract][Full Text] [Related]
16. The effects of cannabidiol (CBD) on Δ⁹-tetrahydrocannabinol (THC) self-administration in male and female Long-Evans rats.
Wakeford AGP; Wetzell BB; Pomfrey RL; Clasen MM; Taylor WW; Hempel BJ; Riley AL
Exp Clin Psychopharmacol; 2017 Aug; 25(4):242-248. PubMed ID: 28682102
[TBL] [Abstract][Full Text] [Related]
17. Age-related differences in Δ⁹-tetrahydrocannabinol-induced antinociception in female and male rats.
Craft RM; Britch SC; Buzitis NW; Clowers BH
Exp Clin Psychopharmacol; 2019 Aug; 27(4):338-347. PubMed ID: 31120286
[TBL] [Abstract][Full Text] [Related]
18. Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
Malone DT; Jongejan D; Taylor DA
Pharmacol Biochem Behav; 2009 Aug; 93(2):91-6. PubMed ID: 19393686
[TBL] [Abstract][Full Text] [Related]
19. Cannabis constituent synergy in a mouse neuropathic pain model.
Casey SL; Atwal N; Vaughan CW
Pain; 2017 Dec; 158(12):2452-2460. PubMed ID: 28885457
[TBL] [Abstract][Full Text] [Related]
20. Effects of Δ⁹-tetrahydrocannabinol (THC), cannabidiol (CBD), and THC/CBD mixtures on fentanyl versus food choice in rhesus monkeys.
Carey LM; Maguire DR; France CP
Drug Alcohol Depend; 2023 Mar; 244():109787. PubMed ID: 36753805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
